Nestle(US:NSRGY) Chang Jiang Shang Bao·2026-01-12 03:07Core Viewpoint - Nestlé is conducting a global recall of certain infant formula products due to potential contamination with Bacillus cereus, a bacteria that can cause foodborne illness, affecting multiple countries and brands [3][4]. Group 1: Recall Details - On January 6, Nestlé China announced a voluntary recall of 71 batches of infant formula, including 41 batches imported from Europe and 30 batches sold in mainland China [1][5]. - The recalled products include various brands such as "Nestlé BEBA Supreme" and "Wyeth启赋未来" [5]. - The recall is a precautionary measure due to quality issues with a specific oil ingredient used in the production of the affected formulas [3][4]. Group 2: Market Impact - As of now, Nestlé China has not received any reports of illness related to the recalled products [2][5]. - The organic sales growth rate for Nestlé's Greater China region was -6.1% for the first three quarters of 2025, with a significant drop of -10.4% in the third quarter [2][7]. - The company is shifting its strategy from a "channel-driven" approach to a "demand-driven" model to address declining sales [2][8]. Group 3: Management Changes and Strategy - Mark Schneider took over as Chairman and CEO of Nestlé Greater China in July 2025, emphasizing the need for a strategic shift in operations [8]. - The previous growth model relied heavily on expanding distribution channels and inventory pressure, which has proven unsustainable [8]. - Schneider has initiated changes in key management positions and integrated e-commerce teams to enhance operational efficiency [8].